Testing a Novel Instagram Intervention for Heavy Alcohol Use
Launched by EMILY GREKIN · May 14, 2024
Trial Information
Current as of February 19, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Ages 18-30
- • Report regular Instagram usage (i.e., at least a few times a week)
- • Report having met the NIAAA's criteria for a binge-drinking episode (4+ drinks in a sitting for cisgender women, 5+ drinks in a sitting for all other genders) at least twice a month for the past three month
- Exclusion Criteria:
- • No exclusion criteria
About Emily Grekin
Emily Grekin is a dedicated clinical trial sponsor known for her commitment to advancing medical research and improving patient outcomes. With a strong background in clinical operations and regulatory affairs, she leads initiatives that prioritize ethical standards and scientific rigor. Under her guidance, trials are meticulously designed and executed, ensuring adherence to regulatory guidelines while fostering innovation in therapeutic development. Emily's collaborative approach promotes strong partnerships with research institutions and stakeholders, ultimately driving the successful translation of clinical findings into real-world applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Detroit, Michigan, United States
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Related articles
